Trade Mark Journal No.2025/040 3 October 2025
WO0000001875991 (5,44)
Office of origin: United States of America
Date of International Registration:18 August 2025
Date of designation in the UK:
18 August 2025

International priority date claimed: 25 February 2025
(United States of America)
(99055267)
- Class 5
- Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders.
- Class 44
- Providing medical information via a website.
INCYTE HOLDINGS CORPORATION
Representative: Frances M. Jagla Christensen O'Connor Johnson Kindness, 1201 Third Avenue, Suite 3600, Seattle WA 98101, UNITED STATES OF AMERICA